CHAM
RCKT icon

Clear Harbor Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Clear Harbor Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,160
Closed -$199K – 420
2022
Q4 		$199K Buy
+10,160
New +$187K 0.02% 319

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Clear Harbor Asset Management's RCKT Position: Q1 2023 in Review

Clear Harbor Asset Management sold out of Rocket Pharmaceuticals (RCKT) in Q1 2023, closing a stake of 10,160 shares — an estimated $199K sold.

Clear Harbor Asset Management first reported a position in RCKT in Q4 2022 and held it in 1 quarter. The position peaked at $199K in Q4 2022. 163 funds tracked by Wall St. Rank hold RCKT as of Q1 2023.

  • Clear Harbor Asset Management reported no remaining Rocket Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Clear Harbor Asset Management sold 10,160 Rocket Pharmaceuticals shares in Q1 2023, an estimated $199K.
  • Clear Harbor Asset Management first reported a position in Rocket Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • Clear Harbor Asset Management's Rocket Pharmaceuticals position peaked at $199K in Q4 2022.
  • 163 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2023.

Based on Clear Harbor Asset Management's 13F filing for Q1 2023, filed 4 May 2023.